Japan · Delayed Price · Currency is JPY Kaken Pharmaceutical Statistics
Total Valuation
TYO:4521 has a market cap or net worth of JPY 144.85 billion. The enterprise value is 89.18 billion.
| Market Cap | 144.85B |
| Enterprise Value | 89.18B |
Important Dates
The last earnings date was Monday, November 9, 2026.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | Mar 30, 2027 |
Share Statistics
TYO:4521 has 37.87 million shares outstanding. The number of shares has decreased by -0.88% in one year.
| Current Share Class | 37.87M |
| Shares Outstanding | 37.87M |
| Shares Change (YoY) | -0.88% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 0.09% |
| Owned by Institutions (%) | 28.22% |
| Float | 34.72M |
Valuation Ratios
The trailing PE ratio is 15.83 and the forward PE ratio is 24.21.
| PE Ratio | 15.83 |
| Forward PE | 24.21 |
| PS Ratio | 1.68 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 1.12 |
| P/FCF Ratio | 19.23 |
| P/OCF Ratio | 12.96 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.88, with an EV/FCF ratio of 11.84.
| EV / Earnings | 9.74 |
| EV / Sales | 1.03 |
| EV / EBITDA | 6.88 |
| EV / EBIT | 9.84 |
| EV / FCF | 11.84 |
Financial Position
The company has a current ratio of 4.17, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.17 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 0.51 |
| Interest Coverage | 161.84 |
Financial Efficiency
Return on equity (ROE) is 6.08% and return on invested capital (ROIC) is 7.31%.
| Return on Equity (ROE) | 6.08% |
| Return on Assets (ROA) | 3.10% |
| Return on Invested Capital (ROIC) | 7.31% |
| Return on Capital Employed (ROCE) | 5.54% |
| Weighted Average Cost of Capital (WACC) | 4.62% |
| Revenue Per Employee | 77.62M |
| Profits Per Employee | 8.22M |
| Employee Count | 1,114 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.89 |
Taxes
In the past 12 months, TYO:4521 has paid 2.42 billion in taxes.
| Income Tax | 2.42B |
| Effective Tax Rate | 20.91% |
Stock Price Statistics
The stock price has increased by +4.80% in the last 52 weeks. The beta is 0.08, so TYO:4521's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | +4.80% |
| 50-Day Moving Average | 3,849.60 |
| 200-Day Moving Average | 3,997.53 |
| Relative Strength Index (RSI) | 50.53 |
| Average Volume (20 Days) | 128,705 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4521 had revenue of JPY 86.47 billion and earned 9.15 billion in profits. Earnings per share was 241.68.
| Revenue | 86.47B |
| Gross Profit | 49.22B |
| Operating Income | 9.06B |
| Pretax Income | 11.57B |
| Net Income | 9.15B |
| EBITDA | 12.96B |
| EBIT | 9.06B |
| Earnings Per Share (EPS) | 241.68 |
Balance Sheet
The company has 59.51 billion in cash and 3.85 billion in debt, with a net cash position of 55.66 billion or 1,469.94 per share.
| Cash & Cash Equivalents | 59.51B |
| Total Debt | 3.85B |
| Net Cash | 55.66B |
| Net Cash Per Share | 1,469.94 |
| Equity (Book Value) | 153.24B |
| Book Value Per Share | 4,046.63 |
| Working Capital | 77.86B |
Cash Flow
In the last 12 months, operating cash flow was 11.18 billion and capital expenditures -3.64 billion, giving a free cash flow of 7.53 billion.
| Operating Cash Flow | 11.18B |
| Capital Expenditures | -3.64B |
| Depreciation & Amortization | 3.90B |
| Net Borrowing | n/a |
| Free Cash Flow | 7.53B |
| FCF Per Share | 198.95 |
Margins
Gross margin is 56.92%, with operating and profit margins of 10.48% and 10.58%.
| Gross Margin | 56.92% |
| Operating Margin | 10.48% |
| Pretax Margin | 13.38% |
| Profit Margin | 10.58% |
| EBITDA Margin | 14.99% |
| EBIT Margin | 10.48% |
| FCF Margin | 8.71% |
Dividends & Yields
This stock pays an annual dividend of 190.00, which amounts to a dividend yield of 4.97%.
| Dividend Per Share | 190.00 |
| Dividend Yield | 4.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 78.88% |
| FCF Payout Ratio | 95.50% |
| Buyback Yield | 0.88% |
| Shareholder Yield | 5.85% |
| Earnings Yield | 6.32% |
| FCF Yield | 5.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for TYO:4521 is 4,575.00, which is 19.61% higher than the current price. The consensus rating is "Hold".
| Price Target | 4,575.00 |
| Price Target Difference | 19.61% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 2.63% |
| EPS Growth Forecast (3Y) | 10.10% |
Stock Splits
The last stock split was on September 28, 2015. It was a reverse split with a ratio of 0.5.
| Last Split Date | Sep 28, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
TYO:4521 has an Altman Z-Score of 4.67 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.67 |
| Piotroski F-Score | 6 |